Cerdanyola del Valles, Spain

Miguel Garcia Martinez


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miguel Garcia Martinez: Innovator in Gene Constructs

Introduction

Miguel Garcia Martinez is a notable inventor based in Cerdanyola del Valles, Spain. He has made significant contributions to the field of genetic engineering, particularly in the development of viral expression constructs. His work focuses on the integration of insulin and glucokinase genes, which has potential applications in medical therapies.

Latest Patents

Miguel Garcia Martinez holds a patent for a "Single-vector gene construct comprising insulin and glucokinase genes." This invention relates to a viral expression construct and related viral vector and composition. The construct comprises elements such as a nucleotide sequence encoding insulin operably linked to a first promoter and a nucleotide sequence encoding glucokinase operably linked to a second promoter. The viral expression construct may also include various configurations of these promoters, enhancing its functionality in gene therapy applications. He has 1 patent to his name.

Career Highlights

Miguel is affiliated with the Universitat Autonoma de Barcelona, where he continues to advance his research in genetic engineering. His academic background and innovative spirit have positioned him as a key figure in his field. His work has the potential to impact diabetes treatment and other metabolic disorders.

Collaborations

Miguel Garcia Martinez collaborates with esteemed colleagues such as Fatima Bosch Tubert and Veronica Jiménez Cenzano. These partnerships enhance the research environment and foster innovation in their projects.

Conclusion

Miguel Garcia Martinez is a pioneering inventor whose work in gene constructs is paving the way for advancements in medical therapies. His contributions to the field of genetic engineering are noteworthy and hold promise for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…